Skip to main content
Category HubUpdated Oct 2026

Muscle Growth Peptides

By the Peptide Dossier Editorial TeamUpdated How we source

Compare GH-related and other muscle-research compounds, the endpoints actually measured, and the difference between hormone signals, body composition and functional benefit.

Category Overview

Many compounds discussed for muscle growth act on GH or IGF-I signaling; others, such as follistatin and BPC-157, address different research questions. An acute rise in a hormone is not a measurement of muscle strength, function or injury recovery.

Effects and risks depend on the molecule, preparation and studied population. A claim that this whole category is milder or safer than anabolic steroids is not established by these sources. Tesamorelin has a specific adult HIV-lipodystrophy indication; that does not make it a general bodybuilding or weight-loss treatment.

Read the actual endpoint: In an ibutamoren trial in older adults, increased fat-free mass did not translate into improved strength or function. A hip-fracture study raised a heart-failure safety signal. Training, nutrition and rehabilitation remain separate clinical questions; this directory does not select a peptide regimen.

How GH Secretagogue Peptides Work

The GH axis has two main stimulatory pathways that peptides can target:

GHRH pathway: CJC-1295 and tesamorelin are GHRH-related compounds. The short human CJC-1295 study measured GH and IGF-I with long-acting material. Its findings should not be assigned to every product called no-DAC CJC-1295.

Ghrelin/GHS-R pathway: Ipamorelin, GHRP-6, GHRP-2 and hexarelin have hormone-release research. Human IV experiments, diagnostic tests and animal selectivity studies address different questions from chronic self-injection or training outcomes.

Combination approach: GHRH and ghrelin-receptor pathways provide a rationale for studying combinations. That rationale and a marketing label such as CJC/Ipa do not establish a standard combined product, a human muscle-gain advantage, or a safe public dose schedule.

All Muscle Growth Peptides

CJC-1295

Short GH/IGF-I studies concern long-acting material; DAC and salt identities matter.

Research
Read full profile →
Ipamorelin

Human IV studies and preclinical selectivity do not establish chronic home-injection safety.

Research
Read full profile →
Tesamorelin

EGRIFTA WR/SV concern adult HIV lipodystrophy and have different doses and handling.

FDA Approved
Read full profile →
MK-677 (Ibutamoren)

FDA states ibutamoren is not approved. Increased fat-free mass did not improve strength/function in one trial; a hip-fracture trial raised a heart-failure signal.

Research
Read full profile →
GHRP-6

Acute human hormone/sleep results and preclinical findings answer different questions.

Research
Read full profile →
GHRP-2

Diagnostic and food-intake experiments do not establish a routine weight-loss or performance regimen.

Research
Read full profile →
Hexarelin

Human hormone, sleep and acute cardiac studies do not establish a routine muscle-building, sleep or chronic cardiac treatment.

Research
Read full profile →
Follistatin

Small human gene-transfer studies report some walking/biopsy benefits, neutral outcomes and design limits. Gene vectors, processed isoforms and injected protein are different interventions; newer plasmid registrations have no posted results. The gene-transfer findings do not establish a protein-injection regimen.

Research
Read full profile →
BPC-157

Limited human reports and a rectal-trial account do not establish a general treatment effect. FDA states the assessed free-base and acetate forms are not components of approved drugs; pending policy review is separate.

Research
Read full profile →
IGF-1 LR3

LR3 cell and rat findings are distinct from native IGF-I and the mecasermin label. Human muscle-gain estimates and a 20–30-hour human half-life are not established by the cited studies; Approval of the distinct medicine mecasermin does not cover LR3.

Research
Read full profile →

Disclaimer: Most muscle growth peptides are research compounds not approved by the FDA for human use. This information is for educational purposes only. Consult a healthcare provider before using any peptide therapy. Do not self-medicate with research chemicals.